Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is a once-weekly injection, full stop. Taking semaglutide every five days — rather than on the same day each week — falls outside the licensed dosing schedule and is not supported by clinical evidence. Some people try it hoping to even out side effects or smooth the curve between doses, but the licensed seven-day interval is the schedule tested for both safety and effectiveness. These are prescription-only medicines; a GPhC-registered prescriber, not a forum, should guide any concerns about your dose timing.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide's half-life in the body is roughly a week, which is precisely why the once-weekly schedule works. If you're wondering whether you can take semaglutide every 5 days, it's worth understanding that compressing the cycle raises trough and peak concentrations in a pattern the licensed dose-escalation studies never tested. That doesn't automatically mean harm, but it does mean the side-effect profile, the titration logic and the effectiveness findings from the STEP 1 trial (published in the New England Journal of Medicine) simply don't apply to a modified interval. Clinical trials that produced the ~15% average weight-loss figure at 2.4 mg ran on a strict seven-day cadence. Borrow the headline number and change the schedule, and you're extrapolating in a direction the evidence can't support.
There's also a practical risk. Someone injecting every five days will run out of pens faster than the prescription covers. That pressure can push people towards unverified sellers, which carries its own serious dangers, as the MHRA has repeatedly warned about fake weight-loss pens circulating online.
The short version: five days is not close enough to count as "roughly weekly" when a medicine's dosing is calibrated to its half-life.
The impulse to change the interval usually comes from one of two places. Some people find that nausea or fatigue peaks in the day or two after the injection, then eases, and they wonder if dosing sooner would keep things steadier. Others notice what's sometimes called a "Wegovy wearing-off" feeling in the days before their next injection and think a shorter gap would help, and the question of taking Wegovy every 2 weeks comes up for similar reasons, as people look for ways to manage how the medicine feels across the cycle. Both are understandable.
The actual fixes, though, are different. Injection-day side effects are usually most pronounced at the start of treatment or after a dose increase, and most people find they settle within a couple of weeks once the body adjusts. Adjusting what you eat on injection day (smaller, lower-fat meals) can take the edge off without touching the schedule at all. The "wearing-off" feeling before a dose is less common with semaglutide than with shorter-acting medicines, partly because of that long half-life. If it's happening, it's worth raising with your prescriber; there may be a different reason behind it.
Our clinical team at nume hears these questions regularly. The answer is almost always about supporting the licensed schedule better, not departing from it.
The Wegovy Patient Information Leaflet does give one flexibility provision: if you miss an injection and the next scheduled dose is more than five days away, you can take the missed dose at that point. If fewer than five days remain before the next scheduled injection, skip it and resume your normal day. This is the only dose-timing flexibility the licence covers, and it's designed to bring you back to a seven-day rhythm, not to establish a five-day one.
You can also shift which day of the week you inject, as long as a minimum gap of four days is maintained during the transition. After that, the new day becomes the fixed weekly schedule. The NHS medicines page for semaglutide explains this clearly and is worth reading alongside your leaflet.
For a broader look at modified intervals (including what happens when people stretch beyond seven days) the pages on taking Wegovy every six days and taking Wegovy every ten days cover those scenarios in detail.
The best version of this treatment is the one you can sustain reliably, same day each week, stored correctly in the fridge, injected as directed. When the pen arrives through DPD in plain packaging, the leaflet inside it is specific about timing for a reason: consistency is part of the mechanism.
If you're finding the current schedule difficult, that's a clinical conversation. A prescriber can explore whether the titration pace, the dose, or something in how the medicine is interacting with other factors needs attention. What they can't support is a five-day interval, because there's no evidence base to prescribe from.
Thinking about starting treatment, or wondering whether Wegovy or tirzepatide suits you better? Our Wegovy overview covers eligibility and what to expect, and the weight-loss treatments page sets out the full picture. For context on how private treatment is priced and what's included, the guide to where to buy Wegovy in the UK is a useful read before you commit to any provider. If a question about your schedule is what's holding you back, start a free consultation and put it to a prescriber directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.